Advertisement

Topics

Akorn Incorporated Company Profile

10:44 EDT 20th September 2017 | BioPortfolio

Akorn, Inc. is a multi-dimensional manufacturer, packager and distributor of high quality pharmaceutical and medical products.

We are committed to meeting the most demanding needs of our customers and the health care community.



We will continue to develop and/or license and deliver specialty ethical and OTC drugs, unique and proprietary medical instruments, and new modalities of therapy that reflect the latest in technological advances.

Location

2500 Millbrook Drive
Buffalo Grove
60089
United States of America

Contact

Phone: 847 236 3800
Email: customer.service@akorn.com


News Articles [16 Associated News Articles listed on BioPortfolio]

Akorn, Inc. Announces Second Quarter 2013 Earnings Release And Conference Call Information

LAKE FOREST, Ill., July 11, 2013 /PRNewswire/ -- Akorn, Inc. (NASDAQ: AKRX) will host a conference call on Tuesday, August 6, 2013, to discuss second quarter 2013 results followed...

Akorn shareholders approve Fresenius Kabi merger

Akorn shareholders have approved a merger with Fresenius Kabi, according to an Akorn press release.Fresenius Kabi announced in April that it would acquire the company for $4.3 billion, or $34 per shar...

Akorn, Inc. Announces Fourth Quarter 2011 Earnings Release and Conference Call Information

LAKE FOREST, Ill., Feb. 7, 2012 /PRNewswire/ -- Akorn, Inc. (NASDAQ: AKRX) will host a conference call on Tuesday, March 6, 2012, to discuss fourth quarter and year-end 2011 results follo...

ROUNDUP 2: Fresenius hofft auf schnelle Akorn-Übernahme - Starkes Jahresviertel

(neu: Aussagen des Fresenius-Chefs Stephan Sturm aus der Analystenkonferenz, Aktienkurse aktualisiert) BAD HOMBURG (dpa-AFX) - Der Medizinkonzern Fresenius hofft nach der Zustimmung der Akorn-Akti...

Akorn, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment Report [Updated: 05052017] Prices from USD $350

Akorn, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investment ReportSummaryMarketline's Akorn, Inc. Mergers Acquisitions MA, Partnerships Alliances and Investments report includes bu...

Why I'm Not Arbing The Fresenius / Akorn Deal

Akorn Shareholders Vote To Approve Merger Agreement With Fresenius Kabi AG

  Life Sciences Jobs   ...

Fresenius-Aktie: Akorn-Übernahme immer näher - Kaufempfehlung bestätigt - Aktienanalyse

Kulmbach - Fresenius-Aktienanalyse von Marion Schlegel von "Der Aktionär": Marion Schlegel, Redakteurin beim Anlegermagazin "Der Aktionär", rät in einer aktuellen Aktienanalyse weiterhin zum Kauf d...

Drugs and Medications [108 Associated Drugs and Medications listed on BioPortfolio]

Gonak hypromellose [Akorn, Inc.]

GONAK™Hypromellose Ophthalmic Demulcent Solution2.5%

Methylene blue [Akorn, Inc.]

Methylene Blue Injection, USP 1%

Ketotifen fumarate [Akorn, Inc.]

Balanced salt [Akorn, Inc.]

BALANCED SALT SOLUTION

Bacitracin zinc and polymyxin b sulfate [STAT RX USA LLC]

BACITRACIN ZINC AND POLYMYXIN B SULFATE ointment [Akorn, Inc.]

PubMed Articles [1 Associated PubMed Articles listed on BioPortfolio]

AERODYNAMIC PROPERTIES AND IN SILICO DEPOSITION OF MELOXICAM POTASSIUM INCORPORATED IN A CARRIER-FREE DPI PULMONARY SYSTEM.

Dry powder inhalers (DPIs) have been among the fastest developing inhaler forms in the past decades. Researches are focusing on the formulation of carrier-free powders to obtain a higher deep-lung dep...

Clinical Trials [1 Associated Clinical Trials listed on BioPortfolio]

Patient Assessment of Topical Anesthetic Effectiveness for Intravitreal Injections

There are currently several different commercially available topical eye drops and gels used to reduce eye discomfort (topical anesthetics) during and after eye injections. Dr. Pollack is ...

Companies [39 Associated Companies listed on BioPortfolio]

Akorn, Inc.

Akorn, Inc. is a niche pharmaceutical company engaged in the development, manufacture and marketing of multisource and branded pharmaceuticals. Akorn has manufacturing facilities ...

Akorn Incorporated

Akorn, Inc. is a multi-dimensional manufacturer, packager and distributor of high quality pharmaceutical and medical products.We are committed to meeting the most demanding needs of our customers and ...

PRAECIS PHARMACEUTICALS INCORPORATED

PRAECIS PHARMACEUTICALS INCORPORATED is a biopharmaceutical company focused on the discovery and development of novel compounds to address unmet medical needs or improve existing therapies.PRAECIS has...

Aciex Therapeutics, Inc.

Aciex Therapeutics, Inc., located in Boston, MA, is a venture-backed ophthalmic pharmaceutical company focused on developing first-in-class products to treat ocular diseases. Exis...

Pharmapraxis

Founded in 2008 by the Axis Biotec Brasil™ group (www.axisbiotec.com.br), PharmaPraxis has incorporated technologies, and will develop and launch biologic products in Brazil....

More Information about "Akorn Incorporated" on BioPortfolio

We have published hundreds of Akorn Incorporated news stories on BioPortfolio along with dozens of Akorn Incorporated Clinical Trials and PubMed Articles about Akorn Incorporated for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Akorn Incorporated Companies in our database. You can also find out about relevant Akorn Incorporated Drugs and Medications on this site too.

Quick Search
Advertisement
 

Relevant Topics

Nutrition
Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...


Corporate Database Quicklinks



Searches Linking to this Company Record